Concepedia

Filip Woestenborghs

FW

Statistics

Publications

8

Citations

339

H-Index

8

Active since

1995

Affiliations

Janssen (Belgium)(Current)

Johnson & Johnson (United States)

University of Manchester

University of Aberdeen

Filip Woestenborghs is an author at Janssen (Belgium) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1995–2012

8

Publications

8

Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation

Frank C. Odds, Luc Vranckx, Filip Woestenborghs · Antimicrobial Agents and Chemotherapy · 1995 · 82 citations · Full text

, , +19

An assessment of the utility of the yeast GreenScreen assay in pharmaceutical screening

Jacky Van Gompel, Filip Woestenborghs, D. Beerens et al. · Mutagenesis · 2005 · 50 citations · Full text

In Vitro and In Vivo Activities of the Novel Azole Antifungal Agent R126638

Frank C. Odds, Jannie Ausma, F. Van Gerven et al. · Antimicrobial Agents and Chemotherapy · 2004 · 49 citations · Full text

, , +14

Interlaboratory assessment of the GreenScreen HC GADD45a-GFP genotoxicity screening assay: An enabling study for independent validation as an alternative method

Nicholas Billinton, Paul W. Hastwell, D. Beerens et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2008 · 41 citations

, , +9

Oxygen as limiting nutrient for growth of Cryptococcus neoformans

Frank C. Odds, T De Backer, Géry Dams et al. · Journal of Clinical Microbiology · 1995 · 39 citations · Full text

, , +10

1–5 of 8